Viemed Healthcare (VMD) Net Cash Flow (QoQ) (2018 - 2026)
Viemed Healthcare (VMD) Net Cash Flow (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn |
| 10 | Viemed Healthcare | 331.21 Mn | 320.53 Mn | 45.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 124.55% |
| Mar 31, 2026 | -257.23% |
| Dec 31, 2025 | 126.74% |
| Sep 30, 2025 | -190.23% |
| Jun 30, 2025 | 233.55% |
| Mar 31, 2025 | -219.17% |
| Dec 31, 2024 | 143.82% |
| Sep 30, 2024 | 69.56% |
| Jun 30, 2024 | 127.09% |
| Mar 31, 2024 | -300.29% |
| Dec 31, 2023 | 1,991.10% |
| Sep 30, 2023 | 98.90% |
| Jun 30, 2023 | -300.90% |
| Mar 31, 2023 | 245.27% |
| Dec 31, 2022 | -927.93% |
| Sep 30, 2022 | 93.94% |
| Jun 30, 2022 | -972.14% |
| Mar 31, 2022 | -45.49% |
| Dec 31, 2021 | 135.97% |
| Sep 30, 2021 | -8,033.33% |